This is a preview of subscription content, log in via an institution to check access.
References
Beggs WH, LaSota IR, Hughes CE. Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis. Eur J Clin Microbiol Infect Dis 1988; 7: 413–14.
Beggs WH. Regulation of the direct fungicidal action of miconazole against Candida albicans ATCC 26790. Mycoses 1988; 31: 226–28.
Beggs WH, Hughes CE. Exploitation of the direct cell damaging action of antifungal azoles. Diagn Microbiol Infect Dis 1987; 6: 1–3.
Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1988; 1: 187–217.
Beggs, WH. Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole. Mycoses 1991; 34: 227–30.
Beggs WH. Resistance to direct lethal miconazole action in Candida albicans induced by 5-fluorocytosine versus lowlevel miconazole. Curr Ther Res 1991; 50: 460–62.
Daneshmend TK, Warnock DW. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinetics 1983; 8: 17–42.
Ringel SM. New antifungal agents for the systemic mycoses. Mycopathologia 1990; 109: 75–87.
Author information
Authors and Affiliations
Additional information
The author's work summarized in this communication was supported by the Department of Veterans Affairs.
Rights and permissions
About this article
Cite this article
Beggs, W.H. Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs. Mycopathologia 120, 131–132 (1992). https://doi.org/10.1007/BF00436388
Issue Date:
DOI: https://doi.org/10.1007/BF00436388